Biogen (BIIB)

Company Ticker Sector | Industry Quality PAR
Biogen BIIB Healthcare | Drug Manufacturers - General 84 6.4%
Current Price (02/24) $282.74
CAPS Rating (Rate this stock on CAPS) Foolcaps 4
Expected Income Statement
Current Sales 13,750.0
Sales Growth Forecast 4.1%
Net Profit Margin 29.2%
Projected Shares Outstanding 140.00
EPS - Five year Forecast $35.13
Average P/E Ratio 11.0
Projected Average Price $386.46
Price Appreciation (Annualized) 6.4%
Annual Dividend Yield 0.0%
Projected Annual Return 6.4%
Quality
Financial Strength 90 22.6
EPS Stability 82 20.5
Industry Sales Growth Rate 8.0% 6.5
Industry Net Profit Margin 22.5% 16.2
Calculated Quality Rating 65.8
Fool CAPS

Total Players

973 Outperforms
71 Underperforms
 

All-Stars (228)

215 Outperforms (94%)
13 Underperforms
 
Fundamental Data Updated: 01/01/2021

MIPAR 5.0%  
Sweet Spot 10.0% - 15.0%  

Top In Drug Manufacturers - General

Ticker Quality PAR
BMY 92 13.8%
RHHBY 87 13.1%
MRK 89 11.9%
AMGN 96 7.9%
JNJ 90 6.9%

Top In Healthcare

Ticker Quality PAR
BMY 92 13.8%
RHHBY 87 13.1%
PKI 88 12.3%
MRK 89 11.9%
ANTM 87 12.2%